Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
Revenue of Disc Medicine, Inc. (IRON)
Revenue in 2023 (TTM): $
According to Disc Medicine, Inc.'s latest financial reports the company's current revenue (TTM) is $. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Disc Medicine, Inc.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $ | $-100,000 | $-91,025,000 | $-76,330,000 | $-76,429,000 |
| 2022 | $ | $-300,000 | $-47,475,000 | $-46,827,000 | $-46,090,000 |
| 2021 | $ | $-192,000 | $-25,851,000 | $-35,969,000 | $-41,005,000 |
| 2020 | $ | $-322,000 | $-33,681,000 | $-40,837,000 | $-47,663,000 |